Table I.
Differentially expressed lncRNAs in the celecoxib and the control groups.
| lncRNAs ID | Celecoxib | Control | Fold change | q value |
|---|---|---|---|---|
| Upregulated | ||||
| lnc-IGFL3-2:1 | 18.43 | 44.60 | 1.27 | 1.07×10−7 |
| lnc-PTMS-1:3 | 427.83 | 613.56 | 0.52 | 1.71×10−6 |
| lnc-SCD-1:13 | 105.06 | 152.80 | 0.54 | 1.71×10−6 |
| lnc-TNS4-2:1 | 6.28 | 15.94 | 1.34 | 1.71×10−6 |
| lnc-TTLL10-3:1 | 7.71 | 11.67 | 0.60 | 2.91×10−5 |
| lnc-CKMT1A-1:1 | 50.37 | 97.92 | 0.96 | 5.80×10−5 |
| lnc-LRR1-1:2 | 4422.95 | 5914.51 | 0.42 | 6.36×10−5 |
| lnc-RAB3IL1-2:1 | 2279.25 | 3231.60 | 0.50 | 7.18×10−4 |
| lnc-JUNB-1:1 | 372.34 | 562.08 | 0.59 | 2.00×10−3 |
| lnc-RP11-259P6.1.1–2:1 | 29.78 | 39.57 | 0.41 | 3.20×10−3 |
| lnc-IGFL2-2:1 | 105.84 | 167.35 | 0.66 | 5.76×10−3 |
| lnc-S100P-3:1 | 142.85 | 240.91 | 0.75 | 6.65×10−3 |
| lnc-SRGAP3-1:29 | 0 | 1.73 | 1.80e+308 | 1.19×10−2 |
| lnc-RAB44-3:1 | 8.43 | 14.88 | 0.82 | 1.25×10−2 |
| lnc-GLTSCR2-2:7 | 18.58 | 26.75 | 0.53 | 1.26×10−2 |
| lnc-PDZD7-3:2 | 0 | 3.41 | 1.80e+308 | 2.41×10−2 |
| lnc-CEACAM6-1:1 | 33.20 | 57.59 | 0.79 | 2.51×10−2 |
| lnc-SPNS3-1:3 | 18.58 | 27.11 | 0.54 | 4.89×10−2 |
| lnc-UNC5B-1:1 | 12.62 | 18.20 | 0.53 | 4.89×10−2 |
| Downregulated | ||||
| lnc-C9orf16-2:1 | 875.46 | 425.36 | −1.04 | 0 |
| lnc-C9orf16-3:1 | 352.54 | 156.14 | −1.17 | 0 |
| lnc-TRIM31-1:2 | 47.17 | 21.45 | −1.14 | 4.10×10−8 |
| lnc-DDX47-3:1 | 211.38 | 145.19 | −0.54 | 1.46×10−7 |
| lnc-PCK1-3:1 | 13.92 | 5.48 | −1.35 | 8.52×10−7 |
| lnc-MYO16-7:1 | 349.12 | 200.98 | −0.80 | 1.71×10−6 |
| lnc-YPEL5-5:1 | 71.82 | 44.54 | −0.69 | 1.71×10−6 |
| lnc-TNK2-8:1 | 16.60 | 2.33 | −2.83 | 4.54×10−6 |
| lnc-AC069257.9.1-4:73 | 124.40 | 66.92 | −0.90 | 6.69×10−5 |
| lnc-CCDC80-1:4 | 18.79 | 3.17 | −2.57 | 1.74×10−3 |
| lnc-AC069257.9.1-4:72 | 151.58 | 81.26 | −0.90 | 5.89×10−3 |
| lnc-KRT36-1:1 | 45.00 | 18.61 | −1.27 | 6.65×10−3 |
| lnc-CCDC33-1:1 | 32.45 | 19.88 | −0.71 | 8.64×10−3 |
| lnc-CXCL3-1:1 | 5.06 | 1.51 | −1.74 | 2.51×10−2 |
| lnc-PDZK1IP1-3:1 | 25.26 | 11.57 | −1.13 | 3.28×10−2 |
| lnc-SUSD3-4:2 | 19.48 | 9.17 | −1.09 | 3.37×10−2 |
| lnc-AC069257.9.1-4:53 | 99.18 | 57.43 | −0.79 | 3.59×10−2 |
| lnc-AP000974.1-1:1 | 36.09 | 16.13 | −1.16 | 4.79×10−2 |
Celecoxib and control columns indicate the average expression values of the lncRNAs in the celecoxib and the control group, respectively. lncRNA, long non-coding ribonucleic acids.